FindTrial
Sign In

Autoimmune Autoantibody Status in Non-autoimmune Encephalopathic Patients

Autoimmune Autoantibody Status in Non-autoimmune Encephalopathic Patients: A Observational Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20201221004
Enrollment
51
Registered
2020-12-21
Start date
2019-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Encephalopathy Autoimmune encephalitis Metabolic encephalopathy Hashimoto&#39

Interventions

Patient admitted in Ramathibodi hospital Age more than 18 years old Clinical encephalopathy either alteration of consciousness&#44
confusion&#44
cognitive impairment&#44
behavioral change Onset less than 3 months
Diagnostic
Encephalopathic patient

Sponsors

the Neurogenetics Fund of Ramathibodi Hospital Foundation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients, who admitted at the Ramathibodi Hospital during June to December 2019 Clinical encephalopathy

Exclusion criteria

Exclusion criteria: Duration of symptoms greater than 3 months Denied consent

Design outcomes

Primary

MeasureTime frame
False positive antibodies among encephalopathic patients 7 months Blood and CSF test—

Secondary

MeasureTime frame
Comparison of clinical characteristic, investigation data, etiology and outcome between false-positi 7 months hospital record review—

Countries

Thailand

Contacts

Public ContactAttawit Charoensri

Ramathibodi hospital

attawit.charoensri@gmail.com0869671717

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026